The short version
Only one company currently supplies this market — there is no backup if it stumbles.
The numbers behind every sentence are on this page below — and the Watch button emails you when any of them move.
Fatigue Formula
Medulla Ossis Suis, Spleen (Bovine), Thymus (Bovine), Carcinosin, Cytomegalovirus Nosode, Influenzinum (2022-2023), Streptococcus Viridans, Toxoplasma Gondii, Epstein-Bar Virus Nosode · SUS SCROFA BONE MARROW 6 [hp_X]/mL; BOS TAURUS SPLEEN 6 [hp_X]/mL; BOS TAURUS THYMUS 6 [hp_X]/mL; HUMAN BREAST TUMOR CELL 16 [hp_X]/mL; HUMAN HERPESVIRUS 5 16 [hp_X]/mL; INFLUENZA A VIRUS A/VICTORIA/2570/2019 IVR-215 (H1N1) ANTIGEN (UV, FORMALDEHYDE INACTIVATED) 16 [hp_X]/mL; INFLUENZA A VIRUS A/DARWIN/9/2021 IVR-228 (H3N2) ANTIGEN (UV, FORMALDEHYDE INACTIVATED) 16 [hp_X]/mL; INFLUENZA B VIRUS B/AUSTRIA/1359417/2021 BVR-26 ANTIGEN (UV, FORMALDEHYDE INACTIVATED) 16 [hp_X]/mL; INFLUENZA B VIRUS B/PHUKET/3073/2013 ANTIGEN (UV, FORMALDEHYDE INACTIVATED) 16 [hp_X]/mL; STREPTOCOCCUS VIRIDANS GROUP 16 [hp_X]/mL; TOXOPLASMA GONDII 16 [hp_X]/mL; HUMAN HERPESVIRUS 4 16 [hp_C]/mL · Spray · Oral · Nutritional Specialties, Inc.
NDC 83027-0022-01 · 60 mL in 1 BOTTLE, SPRAY · UNAPPROVED HOMEOPATHIC · View full market →
Medicare Part D
Medicare Part D does not cover homeopathic products, which are not FDA-approved drugs.
How Part D pricing works →NADAC price per unit
No NADAC pricing on file for this NDC — NADAC covers drugs dispensed by retail community pharmacies.
Supply fragility
Not scored — fragility is computed for NADAC-priced NDCs.
Regulatory
- Application
- —
- TE code
- —
- Approval date
- —
- Patents / exclusivity
- —
Shortage history
No FDA shortage reports for this drug or its presentations.
Recalls (this NDC)
No enforcement reports list this package NDC.
Manufacturers of Medulla Ossis Suis, Spleen (Bovine), Thymus (Bovine), Carcinosin, Cytomegalovirus Nosode, Influenzinum (2022-2023), Streptococcus Viridans, Toxoplasma Gondii, Epstein-Bar Virus Nosode (Spray)
| Labeler | Strength | First seen | Last seen |
|---|---|---|---|
| Nutritional Specialties, Inc. | SUS SCROFA BONE MARROW 6 [hp_X]/mL; BOS TAURUS SPLEEN 6 [hp_X]/mL; BOS TAURUS THYMUS 6 [hp_X]/mL; HUMAN BREAST TUMOR CELL 16 [hp_X]/mL; HUMAN HERPESVIRUS 5 16 [hp_X]/mL; INFLUENZA A VIRUS A/VICTORIA/2570/2019 IVR-215 (H1N1) ANTIGEN (UV, FORMALDEHYDE INACTIVATED) 16 [hp_X]/mL; INFLUENZA A VIRUS A/DARWIN/9/2021 IVR-228 (H3N2) ANTIGEN (UV, FORMALDEHYDE INACTIVATED) 16 [hp_X]/mL; INFLUENZA B VIRUS B/AUSTRIA/1359417/2021 BVR-26 ANTIGEN (UV, FORMALDEHYDE INACTIVATED) 16 [hp_X]/mL; INFLUENZA B VIRUS B/PHUKET/3073/2013 ANTIGEN (UV, FORMALDEHYDE INACTIVATED) 16 [hp_X]/mL; STREPTOCOCCUS VIRIDANS GROUP 16 [hp_X]/mL; TOXOPLASMA GONDII 16 [hp_X]/mL; HUMAN HERPESVIRUS 4 16 [hp_C]/mL | Aug 26, 2026 | Sep 2, 2026 |
| Nutritional Specialties, Inc. | SUS SCROFA BONE MARROW 6 [hp_X]/mL; BOS TAURUS SPLEEN 6 [hp_X]/mL; BOS TAURUS THYMUS 16 [hp_X]/mL; HUMAN BREAST TUMOR CELL 16 [hp_C]/mL; HUMAN HERPESVIRUS 5 16 [hp_X]/mL; INFLUENZA A VIRUS A/VICTORIA/2570/2019 IVR-215 (H1N1) ANTIGEN (UV, FORMALDEHYDE INACTIVATED) 16 [hp_X]/mL; INFLUENZA A VIRUS A/DARWIN/9/2021 IVR-228 (H3N2) ANTIGEN (UV, FORMALDEHYDE INACTIVATED) 16 [hp_X]/mL; INFLUENZA B VIRUS B/AUSTRIA/1359417/2021 BVR-26 ANTIGEN (UV, FORMALDEHYDE INACTIVATED) 16 [hp_X]/mL; INFLUENZA B VIRUS B/PHUKET/3073/2013 ANTIGEN (UV, FORMALDEHYDE INACTIVATED) 16 [hp_X]/mL; STREPTOCOCCUS VIRIDANS GROUP 16 [hp_X]/mL; TOXOPLASMA GONDII 6 [hp_X]/mL; HUMAN HERPESVIRUS 4 16 [hp_X]/mL | Jul 22, 2026 | Aug 19, 2026 |
| Nutritional Specialties, Inc. | BOS TAURUS SPLEEN 6 [hp_X]/mL; BOS TAURUS THYMUS 6 [hp_X]/mL; HUMAN BREAST TUMOR CELL 16 [hp_X]/mL; HUMAN HERPESVIRUS 4 16 [hp_C]/mL; HUMAN HERPESVIRUS 5 16 [hp_X]/mL; INFLUENZA A VIRUS A/DARWIN/9/2021 IVR-228 (H3N2) ANTIGEN (UV, FORMALDEHYDE INACTIVATED) 16 [hp_X]/mL; INFLUENZA A VIRUS A/VICTORIA/2570/2019 IVR-215 (H1N1) ANTIGEN (UV, FORMALDEHYDE INACTIVATED) 16 [hp_X]/mL; INFLUENZA B VIRUS B/AUSTRIA/1359417/2021 BVR-26 ANTIGEN (UV, FORMALDEHYDE INACTIVATED) 16 [hp_X]/mL; INFLUENZA B VIRUS B/PHUKET/3073/2013 ANTIGEN (UV, FORMALDEHYDE INACTIVATED) 16 [hp_X]/mL; STREPTOCOCCUS VIRIDANS GROUP 16 [hp_X]/mL; SUS SCROFA BONE MARROW 6 [hp_X]/mL; TOXOPLASMA GONDII 16 [hp_X]/mL | Jul 15, 2026 | Jul 15, 2026 |
Roster from daily NDC Directory diffs — first/last seen dates start July 2026.
Cite this page
DrugDashboards, "Fatigue Formula — NDC 83027-0022-01," retrieved September 3, 2026, https://drugdashboards.com/drug/83027002201.
Free to cite with attribution — see how the data is put together.